Nexalin Technology (NXL) Receivables - Other (2022)
Nexalin Technology (NXL) recorded quarterly Receivables - Other of $6912.0 in Q3 2022.
Nexalin Technology (NXL) Receivables - Other (2022) Analysis & Trends
Nexalin Technology's Receivables - Other history runs 1 years deep, the most recent figure standing at $6912.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 6,912.00 |
| Sep 30, 2022 | 6,912.00 |